Rocket Pharma names Joseph Manhede principal accounting officer, effective July 8

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc.

RCKT

0.00

  • Rocket Pharmaceuticals said VP of Finance, Senior Controller, Treasurer, Principal Accounting Officer John Militello will resign effective July 7, 2026.
  • Associate VP, Corporate Controller Joseph Manhede will become Principal Accounting Officer effective July 8, 2026.
  • Manhede joined Rocket in April 2026; previously served as vice president, financial controller at Outlook Therapeutics.
  • Earlier roles included senior finance posts at Amneal Pharmaceuticals; began his career at Deloitte as an audit manager.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rocket Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-026982), on June 30, 2026, and is solely responsible for the information contained therein.